The Kable

The Kable

Share this post

The Kable
The Kable
💊 Bayer’s $1.4 billion Leap; Dr Reddy’s and German cannabis; Bharat Biotech to upgrade plants

💊 Bayer’s $1.4 billion Leap; Dr Reddy’s and German cannabis; Bharat Biotech to upgrade plants

Vinod's avatar
Vinod
Apr 04, 2022
∙ Paid

Share this post

The Kable
The Kable
💊 Bayer’s $1.4 billion Leap; Dr Reddy’s and German cannabis; Bharat Biotech to upgrade plants
Share

Hello and welcome back to the week. Have you met XE yet? The UK has. So has Thailand. Coming soon to a lab near you.

In today’s very short Kable: The WHO suspends Covaxin supply; Japan gets a new R&D body; Dr. Reddy’s gets a heart biz; Bayer reloads Leaps; And a peanut allergy vaccine gets manufacturing digs.

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 The Kable
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share